The ConMed VCARE® Retractor/Elevator is indicated for manipulation of the uterus, and iniection of fluids or gases during laparoscopic procedures such as Laparoscopic Assisted Vaginal Hysterectomy (LAVH), Total Laparoscopic Hysterectomy (TLH), minilap, laparoscopic tubal occlusion or diagnostic laparoscopy and also maintains pneumoperitoneum by sealing the vagina once colpotomy is performed.

Device Description

The modified VCARE® (Vaqinal-Cervical-Ahluwalia's-Retractor-Elevator) ("VCARE") is a disposable, single-use device for manipulation of the uterus and cervix in surgical and diagnostic procedures. The modified VCARE consists of an insulated manipulator tube having an inflatable balloon at its distal [to user] end and an anatomically configured cannula/handle for maintaining proper attitude of the uterus at the proximal end. The insulated manipulator tube is marked with reference graduations from the distal end (centimeters). The graduations are provided as a guide for comparison to a graduated uterine sound. VCARE incorporates a cervical cup to provide manipulation of the uterus, and retraction and elevation of the cervix. There are four (4) size variations of cervical cups - Small (S), Medium (M), Large (L), and Extra-Large (XL). The cervical cups are green and provide a colpotomy quide. Sites for suturing are located on the cervical cup. Differences between the predicate device and the modified VCARE improve device performance and functionality for uterine manipulation during the indicated procedures and are limited to: 1) New occluder design for sealing pneumoperitoneum once colpotomy is performed, 2) Improved handle design, and 3) Revised component retention mechanism and balloon length.

AI/ML Overview

The provided documentation is a 510(k) Summary of Safety and Effectiveness for the ConMed VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator). This submission aims to demonstrate substantial equivalence to a predicate device, rather than proving performance against specific acceptance criteria in a detailed clinical study with a defined ground truth.

Therefore, many of the requested elements about acceptance criteria, study design, expert involvement, and ground truth establishment are not explicitly present in the provided text. The submission focuses on non-clinical performance testing and a comparison to a predicate device.

Here's an analysis of the provided information relative to your request:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not present a formal table of acceptance criteria with specific quantitative targets and corresponding reported device performance. Instead, it broadly states that "Design verification demonstrates devices comply with design specifications and applicable sections" of various ISO and AAMI/ANSI standards. The "performance" is described in qualitative terms or by stating equivalence to the predicate.

The following table summarizes the types of performance aspects tested and the general conclusion, as specific numerical acceptance criteria are not provided.

Acceptance Criteria Category (Derived from Testing)	Reported Device Performance
Design Specifications & Standards Compliance	Complies with design specifications and applicable sections of ISO 11607-1:2006 (Sterilization - Packaging), ISO 11135-1:2007 (Sterilization - Ethylene Oxide), AAMI/ANSI ST67:2011 (Sterilization - EO compatibility), ISO 10993-7:2008 (Biocompatibility - EtO Residuals), ISO 594/1:1986 (Conical Fittings), and ISO 594-2:1998 (Luer Fittings).
Component Retention	Product bench testing included component retention. Results demonstrate compliance.
Balloon Performance	Product bench testing included balloon performance. Results demonstrate compliance.
Sealing of Pneumoperitoneum	Product bench testing included sealing of the pneumoperitoneum. Results demonstrate compliance. This is a specific improvement with the "new occluder design."
Material Properties	Product bench testing included material properties. Results demonstrate compliance.
Handle Torque	Product bench testing included handle torque. Results demonstrate compliance.
Ergonomics & Usability (Human Factors)	Product bench testing included ergonomics and usability. Results demonstrate compliance. Design validation testing in simulated use environments demonstrates conformance to user needs and intended use. The "improved handle design" and "revised component retention mechanism and balloon length" aimed to improve functionality based on user feedback.
Biocompatibility	Material analysis and testing demonstrate the patient contacting materials are biocompatible and comply with the requirements of ISO 10993-1:2009.
Substantial Equivalence	The modified VCARE is safe and effective and substantially equivalent to the predicate as demonstrated by non-clinical performance testing for the same intended use/indications for use, target population, principles of operation, performance specifications, and standards for sterilization, packaging, and biocompatibility.

2. Sample Size Used for the Test Set and Data Provenance

Test Set Sample Size: Not explicitly stated. The document refers to "non-clinical bench and simulated use testing" and "product bench testing," but does not provide specific sample sizes (e.g., number of devices tested).
Data Provenance: The testing appears to be internal research and development ("design verification," "design validation testing") conducted by ConMed Corporation. The country of origin for the data is implied to be the United States, given that ConMed Corporation is based in Utica, NY. The testing is described as "simulated use environments," indicating prospective testing within a laboratory or controlled setting.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

This information is not provided. The testing described is primarily engineering and materials performance, not diagnostic performance requiring expert interpretation for ground truth. The document mentions "user review and feedback" as a basis for design improvements, suggesting input from medical professionals indirectly informed the design, but not as part of a formal ground truth establishment for a test set.

4. Adjudication Method for the Test Set

Not applicable. There is no mention of adjudication, as the tests described are objective, non-clinical performance assessments (e.g., material strength, sealing ability, compliance with standards).

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No. This is not an AI/algorithm-based device, nor is it a diagnostic device where MRMC studies are typically performed. The device is a surgical instrument.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

No. This question is not applicable as the device is a physical surgical instrument, not an AI algorithm.

7. The Type of Ground Truth Used

For the non-clinical performance and material testing, the "ground truth" would be the engineering specifications, relevant ISO/AAMI standards, and established physical/chemical properties. For "usability" and "ergonomics," implicit "ground truth" would derive from user feedback and design requirements aimed at surgical efficacy and safety, but not a formally defined ground truth in the context of diagnostic accuracy.

8. The Sample Size for the Training Set

Not applicable. As a physical medical device, there is no "training set" in the context of machine learning or AI algorithms. The design process involves iterative development, testing, and refinement, but not a formally defined training set.

9. How the Ground Truth for the Training Set Was Established

Not applicable. See point 8.

Summary

{0}------------------------------------------------

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 10, 2015

ConMed Corporation Anna D'Lima Senior Specialist, Regulatory Affairs 525 French Road Utica, NY 13502

Re: K142716

Trade/Device Name: VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator) Regulation Number: n/a Regulation Name: Cannula, Manipulator/Injector, Uterine Regulatory Class: n/a Product Code: LKF Dated: January 12, 2015 Received: January 13, 2015

Dear Anna D'Lima,

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Herbert P. Lerner -S

forBenjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K142716

Device Name

VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator)

Indications for Use (Describe)

The ConMed VCARE® Retractor/Elevator is indicated for manipulation of the uterus, and injection of fluids or gases during laparoscopic procedures such as Laparoscopic Assisted Vaginal Hysterectomy (LAVH), Total Laparoscopic Hysterectomy (TLH), minilap, laparoscopic tubal occlusion or diagnostic laparoscopy and also maintains pneumoperitoneum by sealing the vagina once colpotomy is performed.

Type of Use (Select one or both, as applicable)

	Prescription Use (Part 21 CFR 801 Subpart D)
	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary of Safety and Effectiveness

VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator)

In accordance with the requirements of the Safe Medical Device Act of 1990 and 21CFR 807.92, ConMed Corporation is hereby submitting the 510(k) Summary of Safety and Effectiveness for 510(k) number K142716 as of February 9, 2015.

A. Submitter

ConMed Corporation 525 French Road Utica, NY 13502 Establishment Registration: 1320894

B. Company Contact

Anna D'Lima, RAC Senior Specialist, Regulatory Affairs T: (315) 624-3371 F: (315) 624-3225

C. Device Name

Proprietary Name:	VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator)("VCARE")
Common Name:	Cannula, Manipulator/Injector, Uterine
Panel:	Obstetrics/Gynecology
Product Code:	LKF
Device Class:	Unclassified
Regulation Number:	N/A

D. Predicate Device

Device Name:	VCARE® (Vaginal-Cervical-Ahluwalia's-Retractor-Elevator)("VCARE")
Company Name:	ConMed Corporation
510(k):	K071907

E. Device Description

{4}------------------------------------------------

device and the modified VCARE improve device performance and functionality for uterine manipulation during the indicated procedures and are limited to:

1. New occluder design for sealing pneumoperitoneum once colpotomy is performed,
1. Improved handle design, and
1. Revised component retention mechanism and balloon length.

F. Intended Use / Indications for Use

G. Non-clinical Performance Testing

Non-clinical bench and simulated use testing demonstrate that the modified VCARE is substantially equivalent to the predicate device with regard to intended use/ indication for use, materials, technology, and performance. Design verification demonstrates devices comply with design specifications and applicable sections of ISO 11607-1:2006, ISO 11135-1:2007, AAMI/ANSI ST67:2011, ISO 10993-7:2008, ISO 594/1:1986, and ISO 594-2:1998. Product bench testing included component retention, balloon performance, sealing of the pneumoperitoneum, material properties, handle torque, ergonomics, and usability (human factors). Results of design validation testing performed in simulated use environments demonstrate the modified VCARE conforms to user needs and intended use. Material analysis and testing demonstrate the patient contacting materials are biocompatible and comply with the requirements of ISO 10993-1:2009. Performance testing demonstrates that the performance of the modified VCARE is substantially equivalent to the predicate device.

H. Substantial Equivalence

Intended Use/ Indications for Use

There was no change to the intended use or indications for use for the VCARE product in comparison to the predicate device.

Technological Characteristics

As with the predicate device, the modified VCARE continues to function as a disposable, single-use device for manipulation of the uterus and cervix in surgical and diagnostic procedures. The differences in the technological characteristics of the device are improvements in functionality based on user review and feedback since the predicate product clearance. Differences between the modified VCARE and the predicate device are limited to those listed in Section E, 1-3. The differences in technological characteristics between the predicate device and the modified VCARE do not raise different questions of safety and effectiveness. The modified VCARE is safe and effective and substantial equivalent to the predicate as demonstrated by non-clinical performance testing for the same intended use/ indications for use, target population, principles of operation, performance specifications, and standards for sterilization, packaqing, and biocompatibility.

Conclusion -

The differences between the predicate and the modified design do not raise any new risks of safety or efficacy. Supporting information per this premarket submission confirms that the modified VCARE is safe and effective for its intended use and is substantially equivalent to the predicate device.

Regulation Number and Section

§ 884.4530 Obstetric-gynecologic specialized manual instrument.

(a)
Identification. An obstetric-gynecologic specialized manual instrument is one of a group of devices used during obstetric-gynecologic procedures to perform manipulative diagnostic and surgical functions (e.g., dilating, grasping, measuring, and scraping), where structural integrity is the chief criterion of device performance. This type of device consists of the following:(1) An amniotome is an instrument used to rupture the fetal membranes.
(2) A circumcision clamp is an instrument used to compress the foreskin of the penis during circumcision of a male infant.
(3) An umbilical clamp is an instrument used to compress the umbilical cord.
(4) A uterine curette is an instrument used to scrape and remove material from the uterus.
(5) A fixed-size cervical dilator is any of a series of bougies of various sizes used to dilate the cervical os by stretching the cervix.
(6) A uterine elevator is an instrument inserted into the uterus used to lift and manipulate the uterus.
(7) A gynecological surgical forceps is an instrument with two blades and handles used to pull, grasp, or compress during gynecological examination.
(8) A cervical cone knife is a cutting instrument used to excise and remove tissue from the cervix.
(9) A gynecological cerclage needle is a looplike instrument used to suture the cervix.
(10) A hook-type contraceptive intrauterine device (IUD) remover is an instrument used to remove an IUD from the uterus.
(11) A gynecological fibroid screw is an instrument used to hold onto a fibroid.
(12) A uterine sound is an instrument used to determine the depth of the uterus by inserting it into the uterine cavity.
(13) A cytological cervical spatula is a blunt instrument used to scrape and remove cytological material from the surface of the cervix or vagina.
(14) A gynecological biopsy forceps is an instrument with two blades and handles used for gynecological biopsy procedures.
(15) A uterine tenaculum is a hooklike instrument used to seize and hold the cervix or fundus.
(16) An internal pelvimeter is an instrument used within the vagina to measure the diameter and capacity of the pelvis.
(17) A nonmetal vaginal speculum is a nonmetal instrument used to expose the interior of the vagina.
(18) A fiberoptic nonmetal vaginal speculum is a nonmetal instrument, with fiberoptic light, used to expose and illuminate the interior of the vagina.
(b)
Classification. (1) Class II (special controls). The device, when it is an umbilical clamp with or without a cutter, a uterine tenaculum which is sterile and does not use suction and is intended for single use, a nonmetal vaginal speculum, or a fiberoptic nonmetal vaginal speculum, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.(2) Class I for the amniotome, uterine curette, cervical dilator (fixed-size bougies), cerclage needle, IUD remover, uterine sound, and gynecological biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 884.9.